News | July 05, 2024
Cardiological Society of India releases first Indian guidelines for dyslipidemia management
Dyslipidemia is a critical risk factor for cardiovascular diseases
Dyslipidemia is a critical risk factor for cardiovascular diseases
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
Additional data from APPRAISE ATP trial reinforce modular therapy approach
Subscribe To Our Newsletter & Stay Updated
